Quality Assurance & Regulatory Affairs
Navigate complexity. Accelerate approvals. Build lasting value.
Strategic QA/RA for High-Stakes MedTech
Bringing a medical device to market is never a linear process. Regulatory expectations evolve, design decisions carry downstream risk, and investor and leadership pressures heighten at every milestone.
The stakes are high: delays, failed submissions, remediation cycles, or an unscalable product can compromise both market opportunity and business viability. Success requires more than process — it demands deep regulatory expertise, strategic alignment, and a quality-first approach that enables both approval and long-term growth.
A Trusted Partner Across the Full Journey
For more than 25 years, StarFish Medical has partnered with MedTech innovators — from venture-backed startups to enterprise device leaders — helping them navigate regulatory complexity and embed robust quality from the start. Our team works side by side with founders, engineering leaders, and executives to reduce risk, accelerate approvals, and position products for scalable success.
We understand what’s at stake in every phase of development. Our proactive approach to QA/RA ensures regulatory and quality strategy is aligned with your business objectives — not bolted on as an afterthought. We stay engaged across the entire lifecycle, helping you avoid common pitfalls and building lasting market advantage.
Expertise That Drives Success
Regulatory Strategy
Choosing the right regulatory pathway is critical to aligning with market timelines, managing investor expectations, and ensuring global scalability. Missteps at this stage can cause years of delay. StarFish helps clients assess tradeoffs, navigate complex market requirements, and build a regulatory strategy that supports both approval and commercial success.
Regulatory Gap Analysis and/or Transition Planning
Evolving regulations introduce hidden risks that can derail submissions or trigger costly remediation. StarFish conducts proactive gap analyses and transition planning, helping clients strengthen documentation, risk management, and quality systems to meet current and emerging global requirements.
Regulatory Guidance and Training
Internal teams often face unclear or shifting expectations from regulatory bodies. StarFish translates complex regulations into actionable guidance and provides targeted training — building organizational understanding, confidence, and readiness for audits or submissions.
Pre-Submissions and Regulator Engagement
Poorly timed or unfocused regulatory engagement can increase project risk rather than reduce it. StarFish helps clients shape strategic Pre-Submissions and Q-Submissions, guiding content, framing, and regulator interactions to build trust and alignment.
Clinical Submissions
Navigating clinical submission pathways — whether U.S. IDE or Canadian ITA — requires both precision and strategic planning. StarFish supports clients in preparing clear, complete documentation, aligning with regulatory expectations, and coordinating with clinical and ethics partners.
Product Submissions
Successful product submissions demand more than compliant documents — they require clear alignment between design, risk management, and regulatory strategy. StarFish supports clients through the entire submission process, helping ensure clarity, completeness, and strategic positioning for approval.
Quality Management System (QMS) Design and Implementation
A poorly aligned QMS can stall operations, fail audits, or limit scalability. StarFish helps clients design and implement quality systems that fit their business model and global compliance needs — building robust foundations for growth and sustainable compliance.
Mock Audits and Independent Review
Blind spots in quality systems and documentation often surface late — creating delays or risking findings. StarFish provides independent reviews and mock audits, giving clients early visibility into risks and opportunities for improvement before formal inspections.
Verification, Validation, and Risk Management Support
Gaps in V&V planning or weak risk management can undermine both submissions and post-market performance. StarFish helps clients develop and execute strong verification, validation, and risk management practices that meet global regulatory expectations.
Post-Market QA/RA Support
Scaling a product or managing post-market changes introduces new layers of regulatory complexity. StarFish provides ongoing QA/RA leadership — supporting surveillance, change control, and audit readiness to help clients sustain compliance and protect market access.
Aligning Regulatory Strategy with Business Goals
Your regulatory path defines more than compliance — it shapes market timing, informs investor narratives, and determines scalability. The wrong decisions can create years of delay or limit global opportunities.
StarFish collaborates closely with leadership and technical teams to chart regulatory strategies that align with both clinical and commercial goals. Drawing on deep experience with FDA, EU MDR/IVDR, Health Canada, and other global pathways, we help clients choose the right approach for their device and business model — building flexibility and resilience into the strategy from the outset.
Proactive Gap Analysis and Risk Management
Regulatory requirements evolve constantly. Gaps in documentation, testing, or quality processes can derail submissions or trigger post-market challenges.
StarFish conducts proactive gap analyses and regulatory transition planning to keep programs ahead of evolving FDA, EU, Health Canada, and UK expectations. Our team works closely with development and quality leaders to strengthen design controls, risk management, and documentation — reducing late-stage surprises and protecting program momentum.
QA/RA Across the Product Lifecycle
Effective Regulatory Engagement and Communications
Early, strategic engagement with regulators can dramatically reduce risk and accelerate approvals — but poorly framed or mistimed communications often have the opposite effect.
StarFish guides clients through FDA Q-Submissions, Pre-Submissions, and equivalent programs, helping shape clear, well-supported questions and documentation. Our team supports direct interactions with regulatory bodies, helping build trust, align expectations, and remove ambiguity from the path to approval.
Building Quality Systems for Scalable Growth
A robust Quality Management System (QMS) is essential to enabling sustainable operations and market success — especially in fast-scaling MedTech businesses. Weak or poorly aligned systems create friction, delays, and audit risk.
StarFish designs and implements QMS frameworks tailored to each client’s business model and global compliance needs (QMSR, ISO 13485, MDSAP, MDR/IVDR). Our team provides direct support for QMS architecture, documentation, validation, and auditing — ensuring quality systems that enable innovation, efficient operations, and long-term compliance.
Preparing Strong, Confident Submissions
Product submissions represent years of investment — but a poorly prepared or incomplete submission can derail approvals and market plans.
StarFish provides expert guidance and hands-on support for FDA, Health Canada, and EU Notified Body submissions. Our team works across the submission lifecycle — from strategy through document preparation, regulator interactions, and response management — helping ensure each submission is clear, complete, and positioned for success.
Sustaining Quality and Compliance Post-Launch
Regulatory responsibility does not end at market approval. Post-market surveillance, design changes, manufacturing scale-up, and global expansion all require sustained quality leadership.
StarFish provides ongoing QA/RA partnership across the product lifecycle — from design transfer through manufacturing and post-market activities. Our team helps manage change control, risk management, surveillance, and audit readiness — supporting sustained compliance, protecting market access, and enabling global growth.
What Our Clients Have to Say
Ian Maclean
Project ManagerKoven Technology CanadaI commend you for your vision in looking well ahead to regulatory and contract assembly issues, as well as a decision to concurrently develop key prototypes. This ultimately led to a successful design concept. All initial design requirements were satisfied.
Michael Baker
CEOOtoharmonics Corporation“I am extremely happy with StarFish support while setting up a QMS for Otoharmonics and the Levo System tinnitus sound therapy device. I’ve worked with a lot of QMS people in my life and the StarFish team are the most helpful and easy to work with.”
Why Clients Trust StarFish for QA/RA Partnership
- Deep experience across FDA, EU MDR/IVDR, Health Canada, UK, and global regulatory landscapes
- Proven success from early-stage devices to enterprise-scale programs
- Integrated QA/RA leadership that aligns with product and business strategy
- Embedded collaboration across all phases of development — not transactional or isolated Continuous monitoring of evolving regulatory expectations and quality best practices
TL;DR / Key Takeaways
- Strategic QA/RA leadership reduces risk and accelerates approvals
- Regulatory strategy must align with business and market goals
- Early regulatory engagement builds clarity and trust
- A strong QMS supports scalable, sustainable growth
- StarFish provides trusted QA/RA partnership across the full product lifecycle
Ready to Build Strategic QA/RA Advantage?
Speak with an expert to explore how we can help you navigate complexity, mitigate risk, and accelerate market success.
Explore Our Services
Our multidisciplinary teams have all the in-house capabilities to transform your medical device from concept to final product.
Medical device design and development with a commercial launch focus. See how we support clinical trials and facilitate seamless tech transfers.
Ready to experience a smarter way to navigate regulatory compliance?
Impact of FDA Laboratory Developed Tests Policy
Related Resources
Ariana and Mark examine the complexities of endoscope reprocessing, one of the most difficult tasks in medical device hygiene.
Medical device drop testing helps ensure that products and packaging survive real-world handling. We demonstrate in-house drop testing on an actual device and its packaging using a custom-built drop tester.
Medical device startups/founders and enterprise partners have unique strengths and goals, which are often reflected in the way they work with CDMO (Contract Development and Manufacturing Organizations) partners.